Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
World Rank (Aug-2026)
14881
Market Cap (Aug-2026)
0.242 Billion USD
Market Cap (Mar-08-2026)
0.340 Billion USD
World Rank (Jan-05-2024)
16,038
Market Cap (Jan-05-2024)
0.286 Billion USD
World Rank (Jul-30-2023)
22,897
Headquarters Country
Nasdaq / NYSE Code
AKBA
Annual Revenue in USD
236 Million USD
Annual Net Income in USD
-5 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
377 Million USD
Total Liabilities in USD
344 Million USD
Total Equity in USD
33 Million USD
Balance Sheet for Period Ending
As of December-2025
Company Website
Ads